MESNA

MESNA was reported 8486 times

MESNA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE 5 0.5556
1 PLASMABLAST COUNT INCREASED 7 0.5000
2 BLADDER TELANGIECTASIA 6 0.4615
3 T-CELL LYMPHOMA REFRACTORY 11 0.3143
4 PROCTITIS BACTERIAL 5 0.3125
5 LYMPHOID TISSUE HYPOPLASIA 40 0.2614
6 THYMUS HYPOPLASIA 42 0.2414
7 PLASMA CELLS DECREASED 7 0.1400
8 AMNIOTIC FLUID INDEX DECREASED 5 0.1389
9 HUMAN BOCAVIRUS INFECTION 23 0.1217
10 RHABDOID TUMOUR 6 0.1154
11 VULVAL CELLULITIS 5 0.1000
12 VACCINE INDUCED ANTIBODY ABSENT 7 0.0875
13 SECONDARY IMMUNODEFICIENCY 97 0.0798
14 FLAGELLATE DERMATITIS 5 0.0769
15 MYCOBACTERIUM CHELONAE INFECTION 55 0.0744
16 MALASSEZIA INFECTION 5 0.0735
17 PSEUDOMONAL SEPSIS 116 0.0662
18 BK POLYOMAVIRUS TEST POSITIVE 6 0.0625
19 CYSTITIS BACTERIAL 21 0.0621
20 NOROVIRUS TEST POSITIVE 20 0.0615
21 IDIOPATHIC PNEUMONIA SYNDROME 18 0.0604
22 CYSTITIS VIRAL 23 0.0601
23 SARS-COV-2 TEST NEGATIVE 40 0.0593
24 DRUG THERAPEUTIC INCOMPATIBILITY 9 0.0584
25 PARAINFLUENZA VIRUS INFECTION 6 0.0583
26 ANAL INFLAMMATION 37 0.0579
27 CANCER FATIGUE 13 0.0546
28 DISSEMINATED ASPERGILLOSIS 25 0.0530
29 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III 4 0.0506
30 PERICHONDRITIS 5 0.0485
31 ENGRAFT FAILURE 13 0.0453
32 COMBINED IMMUNODEFICIENCY 7 0.0435
33 RED BLOOD CELL TRANSFUSION 16 0.0390
34 HERPES ZOSTER REACTIVATION 10 0.0382
35 CYSTITIS HAEMORRHAGIC 154 0.0382
36 TUMOUR COMPRESSION 12 0.0377
37 ENTEROBACTER BACTERAEMIA 11 0.0363
38 ABSCESS BACTERIAL 13 0.0358
39 ACUTE POLYNEUROPATHY 10 0.0350
40 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
41 CANDIDA TEST POSITIVE 12 0.0287
42 CHRONIC HEPATITIS B 9 0.0284
43 PLATELET TRANSFUSION 35 0.0272
44 FANCONI SYNDROME 38 0.0269
45 ASPERGILLUS TEST POSITIVE 8 0.0260
46 MANTLE CELL LYMPHOMA RECURRENT 11 0.0253
47 VENOOCCLUSIVE DISEASE 62 0.0247
48 METASTASES TO THE MEDIASTINUM 10 0.0243
49 ENGRAFTMENT SYNDROME 14 0.0237
50 PARAINFLUENZAE VIRUS INFECTION 36 0.0236
51 BETA 2 MICROGLOBULIN INCREASED 6 0.0230
52 BILE ACIDS INCREASED 4 0.0226
53 COMPLICATIONS OF BONE MARROW TRANSPLANT 8 0.0222
54 CYTOMEGALOVIRUS ANTIGEN POSITIVE 4 0.0219
55 ENTEROBACTER INFECTION 36 0.0214
56 APLASTIC ANAEMIA 110 0.0210
57 CEREBRAL TOXOPLASMOSIS 19 0.0203
58 ERYTHROPENIA 6 0.0198
59 CYTOMEGALOVIRUS HEPATITIS 7 0.0198
60 FEBRILE NEUTROPENIA 1311 0.0197
61 FUSARIUM INFECTION 13 0.0186
62 SCROTAL PAIN 10 0.0185
63 AMNIOTIC FLUID VOLUME DECREASED 10 0.0183
64 NEUROBLASTOMA 7 0.0183
65 DRUG CLEARANCE INCREASED 4 0.0179
66 APLASIA 35 0.0179
67 CYTOMEGALOVIRUS VIRAEMIA 79 0.0177
68 VIRAEMIA 23 0.0166
69 CHLOROMA 7 0.0166
70 BRONCHOPULMONARY ASPERGILLOSIS 126 0.0162
71 HUMAN HERPESVIRUS 6 INFECTION 30 0.0159
72 OSTEOSARCOMA 6 0.0156
73 CAECITIS 7 0.0156
74 BACTEROIDES INFECTION 4 0.0153
75 VENOOCCLUSIVE LIVER DISEASE 73 0.0148
76 ANTITHROMBIN III DECREASED 4 0.0147
77 MYELOID LEUKAEMIA 7 0.0140
78 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0139
79 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 13 0.0137
80 ENTEROCOCCAL SEPSIS 11 0.0136
81 MUCOSAL INFLAMMATION 347 0.0132
82 STEM CELL TRANSPLANT 33 0.0132
83 PERIORBITAL CELLULITIS 7 0.0130
84 HEPATOBILIARY DISEASE 8 0.0128
85 CHRONIC GRAFT VERSUS HOST DISEASE 46 0.0127
86 VIRAL HAEMORRHAGIC CYSTITIS 9 0.0126
87 FEBRILE BONE MARROW APLASIA 52 0.0122
88 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 4 0.0122
89 DIFFUSE ALVEOLAR DAMAGE 14 0.0122
90 PERIPHERAL MOTOR NEUROPATHY 17 0.0121
91 TOXOPLASMOSIS 13 0.0120
92 PNEUMOTHORAX SPONTANEOUS 8 0.0118
93 URINARY TRACT INFECTION STAPHYLOCOCCAL 5 0.0117
94 CORONA VIRUS INFECTION 5 0.0116
95 KLEBSIELLA BACTERAEMIA 11 0.0116
96 KLEBSIELLA SEPSIS 13 0.0115
97 NEUTROPENIC INFECTION 11 0.0115
98 PULMONARY VENO-OCCLUSIVE DISEASE 8 0.0114
99 ACUTE GRAFT VERSUS HOST DISEASE 52 0.0113
100 OTOTOXICITY 21 0.0113
101 RECTAL ABSCESS 19 0.0113
102 OVARIAN FAILURE 6 0.0112
103 RHINOVIRUS INFECTION 43 0.0110
104 BLADDER IRRITATION 7 0.0109
105 B-CELL TYPE ACUTE LEUKAEMIA 8 0.0109
106 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 30 0.0108
107 EPSTEIN-BARR VIRAEMIA 12 0.0108
108 CENTRAL LINE INFECTION 4 0.0108
109 HAEMATOTOXICITY 102 0.0107
110 PULPITIS DENTAL 10 0.0106
111 GASTROENTERITIS NOROVIRUS 14 0.0105
112 NEUTROPENIC SEPSIS 73 0.0102
113 HYPERTENSIVE EMERGENCY 12 0.0102
114 BONE MARROW TOXICITY 12 0.0101
115 THALAMIC INFARCTION 6 0.0101
116 MUCOSAL DISORDER 10 0.0101
117 CANDIDA SEPSIS 9 0.0100
118 HEART TRANSPLANT 9 0.0099
119 ENCEPHALOPATHY 243 0.0099
120 B-CELL LYMPHOMA RECURRENT 5 0.0092
121 PNEUMOCOCCAL SEPSIS 6 0.0091
122 FOLLICULAR LYMPHOMA 8 0.0091
123 VENA CAVA THROMBOSIS 15 0.0090
124 METAPNEUMOVIRUS INFECTION 7 0.0089
125 HEPATITIS E 14 0.0089
126 CYTOKINE RELEASE SYNDROME 177 0.0088
127 CARDIORENAL SYNDROME 5 0.0087
128 BK VIRUS INFECTION 29 0.0086
129 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 4 0.0086
130 CLOSTRIDIUM DIFFICILE COLITIS 91 0.0086
131 RENAL TUBULAR DISORDER 24 0.0085
132 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
133 PELVIC FLUID COLLECTION 6 0.0085
134 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 12 0.0085
135 BACTERIAL INFECTION 158 0.0085
136 FUNGAL SEPSIS 7 0.0084
137 PNEUMATOSIS INTESTINALIS 24 0.0084
138 DIAPHRAGMATIC PARALYSIS 5 0.0083
139 CYTOMEGALOVIRUS CHORIORETINITIS 16 0.0082
140 BLINDNESS CORTICAL 4 0.0082
141 RELAPSING-REMITTING MULTIPLE SCLEROSIS 7 0.0081
142 B-LYMPHOCYTE COUNT DECREASED 11 0.0081
143 FOETAL GROWTH RESTRICTION 49 0.0081
144 BLOOD CULTURE POSITIVE 24 0.0080
145 FANCONI SYNDROME ACQUIRED 14 0.0080
146 PROCTALGIA 51 0.0079
147 NEUROTOXICITY 138 0.0079
148 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
149 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 6 0.0077
150 EROSIVE OESOPHAGITIS 13 0.0077
151 PNEUMONIA FUNGAL 30 0.0076
152 ADENOVIRUS INFECTION 22 0.0076
153 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
154 SINUSITIS FUNGAL 6 0.0075
155 CORYNEBACTERIUM INFECTION 4 0.0075
156 ASPERGILLUS INFECTION 48 0.0073
157 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 16 0.0072
158 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 6 0.0071
159 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 42 0.0071
160 SARCOMA 8 0.0071
161 LIP HAEMORRHAGE 9 0.0071
162 PERIPHERAL SENSORY NEUROPATHY 41 0.0070
163 LEUKOENCEPHALOPATHY 26 0.0070
164 TOXIC ENCEPHALOPATHY 35 0.0069
165 ASPERGILLOSIS 9 0.0069
166 VENOUS THROMBOSIS 27 0.0069
167 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
168 ESCHERICHIA BACTERAEMIA 16 0.0068
169 MITRAL VALVE DISEASE 12 0.0068
170 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
171 PANCYTOPENIA 373 0.0067
172 MYELODYSPLASTIC SYNDROME 96 0.0066
173 HYPERURICAEMIA 27 0.0066
174 GLOMERULONEPHRITIS 16 0.0065
175 ENTEROCOLITIS INFECTIOUS 6 0.0065
176 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0065
177 GRANULOCYTE COUNT DECREASED 12 0.0065
178 STREPTOCOCCAL BACTERAEMIA 7 0.0064
179 HYPOALBUMINAEMIA 50 0.0064
180 MYOPERICARDITIS 5 0.0064
181 PNEUMONIA STREPTOCOCCAL 7 0.0064
182 CYTOPENIA 78 0.0064
183 FUNGAEMIA 10 0.0063
184 BACILLUS INFECTION 4 0.0063
185 HYPOPROTEINAEMIA 12 0.0063
186 HYPOPHOSPHATAEMIA 46 0.0062
187 FIBRIN D DIMER INCREASED 22 0.0062
188 CYTOMEGALOVIRUS TEST POSITIVE 11 0.0062
189 BLOOD IMMUNOGLOBULIN A DECREASED 4 0.0061
190 BACTERIAL SEPSIS 20 0.0061
191 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 16 0.0061
192 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
193 BACTERAEMIA 72 0.0061
194 CSF PROTEIN INCREASED 5 0.0060
195 DIFFUSE LARGE B-CELL LYMPHOMA 46 0.0060
196 KLEBSIELLA INFECTION 30 0.0059
197 THROMBOTIC MICROANGIOPATHY 57 0.0058
198 DYSPLASIA 7 0.0058
199 CENTRAL NERVOUS SYSTEM LYMPHOMA 8 0.0058
200 TUMOUR LYSIS SYNDROME 51 0.0058
201 RENAL TUBULAR INJURY 7 0.0058
202 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
203 CEREBRAL ARTERY OCCLUSION 6 0.0056
204 GRAFT VERSUS HOST DISEASE 40 0.0056
205 CARDIOTOXICITY 49 0.0055
206 GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0054
207 ENTERITIS 34 0.0053
208 TRANSPLANT FAILURE 13 0.0053
209 SECOND PRIMARY MALIGNANCY 44 0.0053
210 OESOPHAGEAL CANDIDIASIS 21 0.0053
211 STAPHYLOCOCCAL SEPSIS 26 0.0053
212 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
213 STREPTOCOCCAL SEPSIS 6 0.0051
214 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0050
215 VOCAL CORD PARALYSIS 9 0.0050
216 MYELOSUPPRESSION 180 0.0050
217 HYPOGONADISM 5 0.0049
218 CHRONIC HEPATITIS 4 0.0049
219 CATHETER RELATED INFECTION 5 0.0049
220 ANAEMIA HAEMOLYTIC AUTOIMMUNE 4 0.0048
221 NEUTROPHIL COUNT DECREASED 197 0.0048
222 CYTOMEGALOVIRUS INFECTION REACTIVATION 20 0.0045
223 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
224 DRUG LEVEL FLUCTUATING 4 0.0045
225 JUGULAR VEIN THROMBOSIS 8 0.0045
226 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
227 GLYCOSURIA 6 0.0044
228 STENOTROPHOMONAS INFECTION 6 0.0044
229 BLOOD FIBRINOGEN DECREASED 5 0.0044
230 LEUKOPENIA 219 0.0044
231 GASTROINTESTINAL TOXICITY 21 0.0044
232 INTRA-UTERINE DEATH 7 0.0044
233 PNEUMONIA KLEBSIELLA 8 0.0043
234 NEUTROPENIA 587 0.0043
235 HYPOGAMMAGLOBULINAEMIA 28 0.0043
236 FEBRILE INFECTION 5 0.0042
237 NEPHROPATHY TOXIC 47 0.0042
238 HYPERPHOSPHATAEMIA 9 0.0042
239 POLYNEUROPATHY 50 0.0042
240 ENTEROCOCCAL INFECTION 20 0.0041
241 RENAL TUBULAR ACIDOSIS 9 0.0041
242 BONE MARROW DEPRESSION 4 0.0041
243 LYMPHOPENIA 58 0.0041
244 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
245 HYPERBILIRUBINAEMIA 42 0.0041
246 SMALL FOR DATES BABY 20 0.0040
247 BONE MARROW FAILURE 81 0.0040
248 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 38 0.0040
249 SEPTIC SHOCK 173 0.0040
250 GLUCOSE URINE PRESENT 5 0.0039
251 OSTEOLYSIS 8 0.0039
252 CYTOMEGALOVIRUS INFECTION 65 0.0039
253 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
254 SLOW RESPONSE TO STIMULI 5 0.0039
255 NEOPLASM RECURRENCE 13 0.0038
256 DRUG CLEARANCE DECREASED 5 0.0038
257 NON-HODGKIN'S LYMPHOMA 5 0.0038
258 HEPATITIS B 23 0.0038
259 PACKED RED BLOOD CELL TRANSFUSION 5 0.0038
260 LOW BIRTH WEIGHT BABY 30 0.0038
261 ASTERIXIS 4 0.0038
262 LYMPHOCYTE COUNT DECREASED 66 0.0037
263 PULMONARY HAEMORRHAGE 29 0.0037
264 GRANULOCYTOPENIA 21 0.0037
265 PULMONARY TOXICITY 26 0.0037
266 OESOPHAGITIS 40 0.0037
267 VIRAL INFECTION 121 0.0036
268 HYPOKALAEMIA 167 0.0036
269 ENCEPHALITIS 25 0.0036
270 HYPERNATRAEMIA 18 0.0036
271 TACHYARRHYTHMIA 9 0.0036
272 THROMBOCYTOPENIA 401 0.0036
273 SYSTEMIC CANDIDA 9 0.0036
274 HEPATORENAL SYNDROME 6 0.0036
275 CLOSTRIDIAL INFECTION 12 0.0035
276 SKIN WOUND 6 0.0035
277 NOCARDIOSIS 9 0.0035
278 NON-CARDIAC CHEST PAIN 11 0.0035
279 HAEMOLYTIC URAEMIC SYNDROME 8 0.0034
280 ALOPECIA AREATA 6 0.0034
281 MULTI-ORGAN FAILURE 59 0.0034
282 NORMOCYTIC ANAEMIA 5 0.0034
283 ACUTE RESPIRATORY DISTRESS SYNDROME 60 0.0034
284 PULMONARY ALVEOLAR HAEMORRHAGE 19 0.0034
285 CAPILLARY LEAK SYNDROME 7 0.0034
286 DEAFNESS NEUROSENSORY 11 0.0033
287 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 17 0.0033
288 METABOLIC ENCEPHALOPATHY 10 0.0033
289 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
290 CARDIAC FAILURE ACUTE 22 0.0033
291 SEPSIS 367 0.0033
292 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
293 ACCIDENT 39 0.0033
294 ORAL MUCOSAL ERUPTION 5 0.0033
295 PORTAL HYPERTENSION 10 0.0032
296 B-CELL LYMPHOMA 11 0.0032
297 AGRANULOCYTOSIS 60 0.0032
298 MONOPLEGIA 14 0.0032
299 BLOOD LACTATE DEHYDROGENASE INCREASED 51 0.0032
300 MULTIPLE ORGAN DYSFUNCTION SYNDROME 90 0.0032
301 CLOSTRIDIUM TEST POSITIVE 7 0.0032
302 TRANSFUSION 33 0.0031
303 ACUTE MYELOID LEUKAEMIA 49 0.0031
304 BLOOD BILIRUBIN ABNORMAL 4 0.0031
305 THROMBOTIC THROMBOCYTOPENIC PURPURA 11 0.0031
306 FACIAL PARESIS 11 0.0031
307 ESCHERICHIA SEPSIS 9 0.0031
308 STRONGYLOIDIASIS 5 0.0031
309 VENTRICULAR DYSFUNCTION 8 0.0031
310 HAEMORRHOIDS 60 0.0031
311 COVID-19 PNEUMONIA 36 0.0030
312 EPSTEIN-BARR VIRUS INFECTION 19 0.0030
313 ORAL CANDIDIASIS 40 0.0030
314 SEBORRHOEIC DERMATITIS 5 0.0030
315 CYTOLYTIC HEPATITIS 10 0.0030
316 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
317 DEVICE RELATED INFECTION 46 0.0030
318 URINARY TRACT OBSTRUCTION 7 0.0029
319 DRUG TOXICITY 40 0.0029
320 INTRACARDIAC THROMBUS 9 0.0029
321 GASTROINTESTINAL OBSTRUCTION 7 0.0029
322 DIABETES INSIPIDUS 7 0.0029
323 HYPOCALCAEMIA 55 0.0029
324 MENINGITIS ASEPTIC 13 0.0029
325 FUNGAL INFECTION 96 0.0029
326 BLOOD DISORDER 23 0.0029
327 TACHYPNOEA 39 0.0029
328 HYPERVOLAEMIA 14 0.0028
329 HAEMOLYTIC ANAEMIA 25 0.0028
330 HAEMATURIA 95 0.0028
331 HERPES SIMPLEX 18 0.0028
332 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
333 ACUTE PULMONARY OEDEMA 15 0.0027
334 LEFT VENTRICULAR FAILURE 9 0.0026
335 LUNG INFILTRATION 23 0.0026
336 BLOOD CREATININE ABNORMAL 9 0.0026
337 BODY TEMPERATURE INCREASED 53 0.0026
338 PSEUDOMONAS INFECTION 22 0.0026
339 DISSEMINATED INTRAVASCULAR COAGULATION 36 0.0026
340 OCCULT BLOOD POSITIVE 5 0.0025
341 CARDIAC TAMPONADE 12 0.0025
342 LUNG CONSOLIDATION 7 0.0025
343 HAEMODIALYSIS 21 0.0025
344 CANDIDIASIS 10 0.0025
345 TUMOUR HAEMORRHAGE 7 0.0025
346 RESPIRATORY DISTRESS 67 0.0024
347 CHRONIC SINUSITIS 9 0.0024
348 PETECHIAE 25 0.0024
349 DISEASE PROGRESSION 283 0.0024
350 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
351 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
352 SINUS TACHYCARDIA 33 0.0023
353 EJECTION FRACTION DECREASED 36 0.0023
354 MENTAL STATUS CHANGES 64 0.0023
355 HYPOVOLAEMIC SHOCK 11 0.0023
356 CERVICAL DYSPLASIA 5 0.0023
357 CATATONIA 12 0.0023
358 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
359 STOMATITIS 138 0.0023
360 PNEUMOTHORAX 36 0.0023
361 DIASTOLIC DYSFUNCTION 7 0.0023
362 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
363 TRANSAMINASES INCREASED 50 0.0022
364 SPINAL COLUMN INJURY 5 0.0022
365 HYPOXIA 79 0.0022
366 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
367 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
368 PLATELET COUNT DECREASED 236 0.0022
369 HEPATITIS B REACTIVATION 7 0.0022
370 METASTASES TO MENINGES 5 0.0022
371 FOLLICULITIS 23 0.0022
372 ESCHERICHIA INFECTION 18 0.0022
373 ODYNOPHAGIA 13 0.0022
374 ATELECTASIS 21 0.0022
375 METASTASES TO CENTRAL NERVOUS SYSTEM 28 0.0022
376 CONGESTIVE CARDIOMYOPATHY 9 0.0022
377 HEPATOTOXICITY 48 0.0022
378 ANAEMIA 411 0.0022
379 BILIRUBIN CONJUGATED INCREASED 5 0.0021
380 CACHEXIA 11 0.0021
381 NEUTROPHIL COUNT ABNORMAL 6 0.0021
382 HEPATOCELLULAR INJURY 30 0.0021
383 BLOOD BILIRUBIN INCREASED 57 0.0021
384 PLEURAL EFFUSION 128 0.0021
385 METASTASIS 15 0.0021
386 PYREXIA 713 0.0021
387 HYPERTRIGLYCERIDAEMIA 12 0.0020
388 EMBOLISM 17 0.0020
389 MOUTH HAEMORRHAGE 15 0.0020
390 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 21 0.0020
391 LYMPHOPROLIFERATIVE DISORDER 6 0.0020
392 WHITE BLOOD CELL COUNT DECREASED 221 0.0020
393 HEPATOMEGALY 20 0.0020
394 THORACIC VERTEBRAL FRACTURE 6 0.0020
395 HISTIOCYTOSIS HAEMATOPHAGIC 6 0.0020
396 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
397 URINARY TRACT INFECTION BACTERIAL 5 0.0020
398 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
399 MALNUTRITION 22 0.0020
400 CORONAVIRUS INFECTION 13 0.0020
401 C-REACTIVE PROTEIN INCREASED 71 0.0019
402 CELLULITIS 98 0.0019
403 CEREBRAL ISCHAEMIA 10 0.0019
404 HYPOMAGNESAEMIA 27 0.0019
405 RADICULOPATHY 5 0.0019
406 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
407 CARDIOMYOPATHY 28 0.0019
408 HYPOVOLAEMIA 11 0.0019
409 METASTASES TO LIVER 33 0.0019
410 VENTRICULAR HYPOKINESIA 6 0.0019
411 ABDOMINAL MASS 5 0.0019
412 PERICARDIAL EFFUSION 43 0.0019
413 PURPURA 16 0.0018
414 ELECTROLYTE IMBALANCE 21 0.0018
415 BLOOD CREATINE INCREASED 8 0.0018
416 OLIGOHYDRAMNIOS 6 0.0018
417 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
418 ILEUS 22 0.0018
419 RENAL TUBULAR NECROSIS 17 0.0017
420 RENAL FAILURE ACUTE 73 0.0017
421 URINE OUTPUT DECREASED 15 0.0017
422 METASTASES TO BONE 28 0.0017
423 COLITIS 64 0.0017
424 HAEMOLYSIS 13 0.0017
425 STILLBIRTH 8 0.0017
426 BONE MARROW DISORDER 5 0.0017
427 GUILLAIN-BARRE SYNDROME 8 0.0017
428 VARICES OESOPHAGEAL 5 0.0017
429 HEMIPARESIS 28 0.0017
430 FLUID OVERLOAD 24 0.0016
431 EMBOLISM VENOUS 5 0.0016
432 PNEUMONIA BACTERIAL 15 0.0016
433 PREMATURE DELIVERY 26 0.0016
434 ATRIAL FLUTTER 13 0.0016
435 ORGANISING PNEUMONIA 8 0.0016
436 DELIRIUM 56 0.0016
437 OLIGURIA 10 0.0016
438 LYMPHOEDEMA 11 0.0016
439 MITRAL VALVE INCOMPETENCE 18 0.0016
440 CATHETER SITE INFECTION 6 0.0016
441 ALANINE AMINOTRANSFERASE INCREASED 97 0.0016
442 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
443 PNEUMONIA VIRAL 5 0.0016
444 HYPERGLYCAEMIA 57 0.0016
445 LYMPHADENOPATHY 55 0.0016
446 PAPILLOEDEMA 7 0.0015
447 PORTAL VEIN THROMBOSIS 5 0.0015
448 PNEUMONITIS 42 0.0015
449 PULMONARY HYPERTENSION 32 0.0015
450 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
451 THERAPY NON-RESPONDER 67 0.0015
452 GAMMA-GLUTAMYLTRANSFERASE INCREASED 33 0.0015
453 TACHYCARDIA 132 0.0015
454 STAPHYLOCOCCAL INFECTION 49 0.0015
455 ADRENAL INSUFFICIENCY 18 0.0015
456 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
457 HYPONATRAEMIA 83 0.0015
458 HYDRONEPHROSIS 11 0.0015
459 NEUTROPHIL COUNT INCREASED 15 0.0015
460 ECCHYMOSIS 10 0.0015
461 WOUND COMPLICATION 5 0.0015
462 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
463 RESPIRATORY FAILURE 106 0.0015
464 ASPARTATE AMINOTRANSFERASE INCREASED 77 0.0014
465 SINUS BRADYCARDIA 14 0.0014
466 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
467 COAGULOPATHY 24 0.0014
468 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
469 ANGIOPATHY 8 0.0014
470 INFECTION 206 0.0014
471 TYPE I HYPERSENSITIVITY 5 0.0014
472 HYPERPYREXIA 6 0.0014
473 STATUS EPILEPTICUS 16 0.0014
474 THERAPY PARTIAL RESPONDER 22 0.0014
475 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
476 MYOCARDIAL ISCHAEMIA 16 0.0014
477 ORAL HERPES 27 0.0014
478 ACUTE KIDNEY INJURY 211 0.0014
479 BRADYPHRENIA 9 0.0014
480 DIVERTICULUM INTESTINAL 6 0.0014
481 PETIT MAL EPILEPSY 7 0.0014
482 BLOOD PHOSPHORUS DECREASED 5 0.0014
483 GROIN PAIN 12 0.0014
484 THROMBOCYTOSIS 5 0.0014
485 CANDIDA INFECTION 23 0.0014
486 AMYLASE INCREASED 5 0.0014
487 TONSILLITIS 7 0.0013
488 HICCUPS 11 0.0013
489 SUSPECTED OFF LABEL USE 6 0.0013
490 PROTEIN TOTAL DECREASED 5 0.0013
491 POLYARTHRITIS 7 0.0013
492 LEUKOCYTOSIS 24 0.0013
493 CHEMOTHERAPY 5 0.0013
494 NYSTAGMUS 7 0.0013
495 HAEMOGLOBIN DECREASED 135 0.0013
496 HAEMODYNAMIC INSTABILITY 10 0.0013
497 HYPERTHERMIA 10 0.0013
498 ACIDOSIS 10 0.0013
499 COMMUNICATION DISORDER 5 0.0013
500 HAEMATEMESIS 33 0.0013
501 LOCALISED OEDEMA 6 0.0013
502 TOXIC SKIN ERUPTION 13 0.0013
503 CYSTITIS 41 0.0013
504 BLOOD BLISTER 4 0.0013
505 ANURIA 11 0.0013
506 PULMONARY MASS 19 0.0013
507 BLOOD ALBUMIN DECREASED 10 0.0013
508 APHASIA 38 0.0013
509 STREPTOCOCCAL INFECTION 7 0.0013
510 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
511 VENTRICULAR EXTRASYSTOLES 13 0.0013
512 HYPOPHAGIA 32 0.0013
513 CUSHINGOID 4 0.0012
514 LUNG INFECTION 19 0.0012
515 ABNORMAL FAECES 10 0.0012
516 CARDIOMEGALY 15 0.0012
517 ANAPHYLACTOID REACTION 5 0.0012
518 METABOLIC DISORDER 7 0.0012
519 DERMATITIS EXFOLIATIVE 6 0.0012
520 HEPATIC FAILURE 36 0.0012
521 NERVE COMPRESSION 11 0.0012
522 GRAND MAL CONVULSION 11 0.0012
523 ASCITES 35 0.0012
524 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
525 HALLUCINATIONS, MIXED 5 0.0012
526 BRAIN OEDEMA 15 0.0012
527 WOUND INFECTION 13 0.0012
528 HYPOTENSION 237 0.0012
529 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
530 PHLEBITIS 6 0.0012
531 FAILURE TO THRIVE 6 0.0012
532 HEPATIC FUNCTION ABNORMAL 43 0.0012
533 HYPERTRANSAMINASAEMIA 8 0.0011
534 TENSION 7 0.0011
535 SMALL INTESTINAL OBSTRUCTION 14 0.0011
536 NEUROPATHY PERIPHERAL 108 0.0011
537 RESPIRATORY RATE INCREASED 10 0.0011
538 STEVENS-JOHNSON SYNDROME 25 0.0011
539 GASTRITIS 29 0.0011
540 GASTROENTERITIS 16 0.0011
541 PREMATURE BABY 33 0.0011
542 ASPIRATION 12 0.0011
543 MALIGNANT NEOPLASM PROGRESSION 112 0.0011
544 SKIN TOXICITY 6 0.0011
545 HYPERKALAEMIA 37 0.0011
546 PULSE ABSENT 5 0.0011
547 ENTEROCOLITIS 6 0.0010
548 BLOOD URIC ACID INCREASED 6 0.0010
549 CHILLS 121 0.0010
550 CAESAREAN SECTION 12 0.0010
551 CARDIOPULMONARY FAILURE 4 0.0010
552 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
553 HEPATIC CYTOLYSIS 13 0.0010
554 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
555 HAIR GROWTH ABNORMAL 7 0.0010
556 GENERAL PHYSICAL HEALTH DETERIORATION 117 0.0010
557 FACE OEDEMA 17 0.0010
558 TRICUSPID VALVE INCOMPETENCE 8 0.0010
559 ANAL INCONTINENCE 9 0.0010
560 SHOCK 23 0.0010
561 PLATELET COUNT ABNORMAL 6 0.0010
562 RASH MACULO-PAPULAR 22 0.0010
563 HYPOTHERMIA 10 0.0010
564 POLYURIA 8 0.0010
565 UROSEPSIS 9 0.0010
566 GENERALISED OEDEMA 12 0.0010
567 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
568 BLOOD CREATININE INCREASED 63 0.0010
569 APPENDICITIS 9 0.0010
570 PERIORBITAL OEDEMA 5 0.0010
571 EPISTAXIS 72 0.0010
572 MYOCARDITIS 11 0.0010
573 DISORIENTATION 38 0.0010
574 SERUM FERRITIN INCREASED 5 0.0009
575 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
576 MEDICAL DEVICE COMPLICATION 7 0.0009
577 AORTIC VALVE INCOMPETENCE 4 0.0009
578 ABSCESS LIMB 4 0.0009
579 FACIAL PARALYSIS 8 0.0009
580 ACUTE RESPIRATORY FAILURE 18 0.0009
581 SKIN HYPERPIGMENTATION 8 0.0009
582 NERVOUS SYSTEM DISORDER 29 0.0009
583 LIVER FUNCTION TEST ABNORMAL 27 0.0009
584 CONFUSIONAL STATE 150 0.0009
585 INCOHERENT 6 0.0009
586 HYDROCEPHALUS 5 0.0009
587 POLYP 6 0.0009
588 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
589 PNEUMONIA 296 0.0009
590 BRONCHOSPASM 13 0.0009
591 RENAL FAILURE CHRONIC 7 0.0009
592 CARDIAC ARREST 75 0.0009
593 HYPERKERATOSIS 5 0.0009
594 LYMPHOMA 14 0.0009
595 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
596 HEPATITIS 23 0.0009
597 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
598 INTESTINAL PERFORATION 10 0.0009
599 CARDIO-RESPIRATORY ARREST 37 0.0009
600 PNEUMONIA ASPIRATION 22 0.0009
601 PRODUCT USE IN UNAPPROVED INDICATION 216 0.0009
602 HERPES VIRUS INFECTION 5 0.0009
603 COMA 41 0.0009
604 TOXICITY TO VARIOUS AGENTS 145 0.0009
605 SHOCK HAEMORRHAGIC 7 0.0009
606 DECUBITUS ULCER 7 0.0009
607 ERYTHEMA MULTIFORME 8 0.0009
608 RIGHT VENTRICULAR FAILURE 6 0.0009
609 DUODENAL ULCER 6 0.0008
610 ACUTE CORONARY SYNDROME 7 0.0008
611 METABOLIC ACIDOSIS 27 0.0008
612 ATAXIA 10 0.0008
613 ATRIAL FIBRILLATION 82 0.0008
614 DEAFNESS 22 0.0008
615 RED BLOOD CELL COUNT DECREASED 24 0.0008
616 RENAL FAILURE 111 0.0008
617 PULMONARY CONGESTION 11 0.0008
618 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
619 CYANOSIS 13 0.0008
620 VOMITING 387 0.0008
621 ORAL DISORDER 6 0.0008
622 DEEP VEIN THROMBOSIS 53 0.0008
623 BREATH SOUNDS ABNORMAL 4 0.0008
624 NEOPLASM PROGRESSION 28 0.0008
625 PANCREATITIS ACUTE 18 0.0008
626 SPINAL OSTEOARTHRITIS 7 0.0008
627 OSTEONECROSIS 26 0.0008
628 DRUG INTERACTION 125 0.0008
629 SUBARACHNOID HAEMORRHAGE 8 0.0008
630 GASTROINTESTINAL INFECTION 7 0.0008
631 METASTASES TO LUNG 9 0.0008
632 DRUG RESISTANCE 20 0.0008
633 HAEMOGLOBIN ABNORMAL 5 0.0008
634 URINARY INCONTINENCE 23 0.0008
635 UNRESPONSIVE TO STIMULI 20 0.0008
636 RESPIRATORY TRACT INFECTION 20 0.0008
637 DERMATITIS 16 0.0008
638 OFF LABEL USE 665 0.0008
639 MYOCLONUS 9 0.0008
640 CONVULSION 43 0.0008
641 CHOLECYSTITIS CHRONIC 5 0.0007
642 ANAL FISSURE 4 0.0007
643 COLITIS ISCHAEMIC 5 0.0007
644 PULMONARY OEDEMA 33 0.0007
645 PROTEINURIA 14 0.0007
646 HYPERCALCAEMIA 9 0.0007
647 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
648 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
649 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
650 SKIN INFECTION 8 0.0007
651 OXYGEN SATURATION DECREASED 40 0.0007
652 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
653 DYSURIA 26 0.0007
654 DIVERTICULUM 5 0.0007
655 PANCREATITIS 37 0.0007
656 FULL BLOOD COUNT DECREASED 14 0.0007
657 DIPLOPIA 18 0.0007
658 PYELONEPHRITIS 6 0.0007
659 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
660 DERMATITIS BULLOUS 5 0.0007
661 FEEDING DISORDER 14 0.0007
662 DEHYDRATION 92 0.0007
663 MADAROSIS 8 0.0007
664 DYSKINESIA 28 0.0007
665 VASCULITIS 8 0.0007
666 IMMUNOSUPPRESSION 6 0.0007
667 INFUSION RELATED REACTION 45 0.0007
668 DRUG EXPOSURE DURING PREGNANCY 23 0.0007
669 DISEASE RECURRENCE 32 0.0007
670 CHOLECYSTITIS 8 0.0007
671 IMMUNODEFICIENCY 10 0.0007
672 SUNBURN 5 0.0007
673 ORAL PAIN 15 0.0007
674 RASH PAPULAR 15 0.0007
675 HAEMORRHAGE INTRACRANIAL 10 0.0007
676 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
677 LIPASE INCREASED 5 0.0007
678 PULMONARY EMBOLISM 62 0.0007
679 SKIN LACERATION 7 0.0006
680 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
681 APNOEA 5 0.0006
682 DIARRHOEA HAEMORRHAGIC 6 0.0006
683 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
684 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
685 DIALYSIS 9 0.0006
686 RHINITIS 5 0.0006
687 VITAMIN D DEFICIENCY 6 0.0006
688 HYPERTENSION 130 0.0006
689 OEDEMA 33 0.0006
690 RENAL IMPAIRMENT 51 0.0006
691 BRADYCARDIA 32 0.0006
692 SPLENOMEGALY 7 0.0006
693 BRONCHIECTASIS 4 0.0006
694 HERPES ZOSTER 34 0.0006
695 CIRCULATORY COLLAPSE 10 0.0006
696 ACUTE HEPATIC FAILURE 8 0.0006
697 HEPATIC CIRRHOSIS 11 0.0006
698 HALLUCINATION 44 0.0006
699 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
700 ABDOMINAL PAIN 134 0.0006
701 FACIAL PAIN 5 0.0006
702 DECREASED APPETITE 130 0.0006
703 CEREBRAL HAEMORRHAGE 20 0.0006
704 RHINORRHOEA 36 0.0006
705 HAEMATOCRIT DECREASED 11 0.0006
706 FOETAL EXPOSURE DURING PREGNANCY 45 0.0006
707 MYDRIASIS 7 0.0005
708 AGITATION 40 0.0005
709 PRODUCT ADMINISTRATION ERROR 11 0.0005
710 URINARY RETENTION 18 0.0005
711 PLATELET COUNT INCREASED 7 0.0005
712 DIARRHOEA 346 0.0005
713 CARDIAC FAILURE 43 0.0005
714 FLANK PAIN 5 0.0005
715 BLOOD POTASSIUM DECREASED 16 0.0005
716 PERITONITIS 11 0.0005
717 BLOOD SODIUM DECREASED 10 0.0005
718 LEUKAEMIA 5 0.0005
719 MOUTH ULCERATION 11 0.0005
720 LETHARGY 30 0.0005
721 SEROTONIN SYNDROME 10 0.0005
722 JAUNDICE 14 0.0005
723 AFFECT LABILITY 5 0.0005
724 LIVER DISORDER 23 0.0005
725 OEDEMA PERIPHERAL 63 0.0005
726 EOSINOPHILIA 9 0.0005
727 COLD SWEAT 9 0.0005
728 ISCHAEMIC STROKE 9 0.0005
729 ULCER 8 0.0005
730 GASTROENTERITIS VIRAL 9 0.0005
731 OSTEOMYELITIS 9 0.0005
732 NO THERAPEUTIC RESPONSE 6 0.0005
733 TOOTH ABSCESS 5 0.0005
734 MOTOR DYSFUNCTION 5 0.0005
735 SUBDURAL HAEMATOMA 7 0.0005
736 CARDIOGENIC SHOCK 7 0.0005
737 NAUSEA 381 0.0005
738 SKIN DISORDER 16 0.0005
739 DYSARTHRIA 18 0.0005
740 BLOOD UREA INCREASED 8 0.0005
741 CONSTIPATION 104 0.0005
742 PERICARDITIS 8 0.0005
743 INTERSTITIAL LUNG DISEASE 23 0.0005
744 INCONTINENCE 5 0.0005
745 SUDDEN DEATH 5 0.0005
746 SYNCOPE 47 0.0005
747 CHOLESTASIS 9 0.0005
748 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
749 ANAPHYLACTIC SHOCK 12 0.0005
750 HYPOAESTHESIA ORAL 7 0.0005
751 BLOOD MAGNESIUM DECREASED 4 0.0005
752 URINARY TRACT INFECTION 79 0.0005
753 ORTHOSTATIC HYPOTENSION 8 0.0005
754 DYSPHAGIA 43 0.0005
755 DENTAL CARIES 5 0.0005
756 BACK PAIN 105 0.0005
757 COGNITIVE DISORDER 21 0.0004
758 DRUG-INDUCED LIVER INJURY 14 0.0004
759 INFLAMMATION 23 0.0004
760 PALLOR 12 0.0004
761 GINGIVAL BLEEDING 6 0.0004
762 ABSCESS 7 0.0004
763 MICTURITION URGENCY 5 0.0004
764 PLASMA CELL MYELOMA 17 0.0004
765 NEOPLASM 5 0.0004
766 RESPIRATORY DISORDER 13 0.0004
767 CONJUNCTIVITIS 8 0.0004
768 EYELID OEDEMA 5 0.0004
769 PAIN IN JAW 12 0.0004
770 PRODUCT USE ISSUE 79 0.0004
771 PARALYSIS 6 0.0004
772 HYPERLIPIDAEMIA 5 0.0004
773 RASH ERYTHEMATOUS 20 0.0004
774 NOCTURIA 5 0.0004
775 METRORRHAGIA 7 0.0004
776 RESPIRATORY DEPRESSION 5 0.0004
777 SEIZURE 47 0.0004
778 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
779 PHARYNGITIS 5 0.0004
780 ARRHYTHMIA 19 0.0004
781 DYSPNOEA EXERTIONAL 15 0.0004
782 DIVERTICULITIS 11 0.0004
783 EPILEPSY 12 0.0004
784 ANOREXIA 5 0.0004
785 BONE DISORDER 7 0.0004
786 ANAPHYLACTIC REACTION 21 0.0004
787 HALLUCINATION, VISUAL 8 0.0004
788 HEPATIC STEATOSIS 7 0.0004
789 BONE PAIN 22 0.0004
790 TREATMENT FAILURE 31 0.0004
791 RENAL INJURY 11 0.0004
792 PRESYNCOPE 9 0.0004
793 BLOOD URINE PRESENT 7 0.0004
794 LUNG DISORDER 18 0.0004
795 PRODUCT PRESCRIBING ISSUE 8 0.0004
796 HEPATIC ENZYME INCREASED 25 0.0004
797 LIVER INJURY 9 0.0004
798 ALOPECIA 72 0.0004
799 RENAL DISORDER 17 0.0004
800 PERIPHERAL COLDNESS 5 0.0004
801 VENTRICULAR TACHYCARDIA 6 0.0004
802 SPEECH DISORDER 19 0.0004
803 POLLAKIURIA 15 0.0004
804 COORDINATION ABNORMAL 5 0.0004
805 BLOOD CALCIUM DECREASED 4 0.0004
806 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
807 SPINAL FRACTURE 7 0.0003
808 HEAD INJURY 11 0.0003
809 HAEMATOMA 9 0.0003
810 MUSCLE TWITCHING 8 0.0003
811 THERAPEUTIC RESPONSE DECREASED 21 0.0003
812 DRUG ERUPTION 6 0.0003
813 TREMOR 56 0.0003
814 MUSCULAR WEAKNESS 38 0.0003
815 SYNOVITIS 6 0.0003
816 BLOOD PRESSURE DECREASED 22 0.0003
817 PELVIC PAIN 6 0.0003
818 ABNORMAL BEHAVIOUR 13 0.0003
819 HAEMORRHAGE 34 0.0003
820 FAECES DISCOLOURED 7 0.0003
821 SOMNOLENCE 65 0.0003
822 CHEST DISCOMFORT 33 0.0003
823 DELUSION 5 0.0003
824 MELAENA 7 0.0003
825 DERMATITIS ALLERGIC 4 0.0003
826 FLUID RETENTION 16 0.0003
827 PRODUCTIVE COUGH 15 0.0003
828 ILL-DEFINED DISORDER 19 0.0003
829 GASTROINTESTINAL DISORDER 28 0.0003
830 ASTHENIA 117 0.0003
831 DYSTONIA 6 0.0003
832 DYSPNOEA 175 0.0003
833 CHOLELITHIASIS 10 0.0003
834 DEATH 261 0.0003
835 CHRONIC KIDNEY DISEASE 23 0.0003
836 MYALGIA 51 0.0003
837 THROMBOSIS 24 0.0003
838 ANGIOEDEMA 13 0.0003
839 COUGH 82 0.0003
840 SCAR 5 0.0003
841 HAEMOPTYSIS 8 0.0003
842 LOCAL SWELLING 5 0.0003
843 WEIGHT DECREASED 79 0.0003
844 IRRITABILITY 17 0.0003
845 TOOTHACHE 5 0.0003
846 END STAGE RENAL DISEASE 5 0.0003
847 IMPAIRED HEALING 9 0.0003
848 CARDIAC FAILURE CONGESTIVE 22 0.0003
849 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
850 SKIN ULCER 7 0.0003
851 OROPHARYNGEAL PAIN 25 0.0003
852 CHEST PAIN 50 0.0003
853 LACRIMATION INCREASED 8 0.0003
854 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
855 SWELLING FACE 17 0.0003
856 EXPOSURE DURING PREGNANCY 16 0.0003
857 PAIN 158 0.0003
858 FATIGUE 200 0.0003
859 BASAL CELL CARCINOMA 4 0.0003
860 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
861 WHEEZING 15 0.0003
862 PREGNANCY 5 0.0002
863 SKIN EXFOLIATION 21 0.0002
864 HEADACHE 156 0.0002
865 DRUG INTOLERANCE 24 0.0002
866 LACTIC ACIDOSIS 8 0.0002
867 NEURALGIA 6 0.0002
868 RESTLESSNESS 9 0.0002
869 CARDIAC DISORDER 23 0.0002
870 DRUG LEVEL INCREASED 4 0.0002
871 EXTRAPYRAMIDAL DISORDER 6 0.0002
872 TINNITUS 11 0.0002
873 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
874 CARDIOVASCULAR DISORDER 6 0.0002
875 RASH 103 0.0002
876 OSTEOARTHRITIS 10 0.0002
877 UNDERDOSE 17 0.0002
878 VAGINAL HAEMORRHAGE 10 0.0002
879 MENTAL DISORDER 10 0.0002
880 PRODUCT DISPENSING ERROR 5 0.0002
881 ERYTHEMA 47 0.0002
882 HYPOGLYCAEMIA 11 0.0002
883 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
884 NEOPLASM MALIGNANT 15 0.0002
885 OSTEOPOROSIS 9 0.0002
886 SINUSITIS 22 0.0002
887 WOUND 6 0.0002
888 HYPOAESTHESIA 32 0.0002
889 VERTIGO 13 0.0002
890 HYPERHIDROSIS 27 0.0002
891 PAIN IN EXTREMITY 61 0.0002
892 ACUTE MYOCARDIAL INFARCTION 6 0.0002
893 RASH PRURITIC 11 0.0002
894 DISABILITY 4 0.0002
895 OSTEONECROSIS OF JAW 5 0.0002
896 ABDOMINAL DISTENSION 21 0.0002
897 MALAISE 87 0.0002
898 PARAESTHESIA 31 0.0002
899 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
900 LOSS OF CONSCIOUSNESS 25 0.0002
901 MUSCULOSKELETAL PAIN 10 0.0002
902 INSOMNIA 50 0.0002
903 FLUSHING 19 0.0002
904 MOVEMENT DISORDER 6 0.0002
905 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
906 RECTAL HAEMORRHAGE 8 0.0002
907 NIGHT SWEATS 6 0.0002
908 BALANCE DISORDER 16 0.0002
909 SKIN LESION 5 0.0002
910 THERAPY INTERRUPTED 13 0.0002
911 HAEMATOCHEZIA 10 0.0002
912 CHROMATURIA 4 0.0002
913 BLOOD PRESSURE INCREASED 27 0.0002
914 DYSGEUSIA 13 0.0002
915 ABDOMINAL PAIN UPPER 36 0.0002
916 DRUG INEFFECTIVE 229 0.0002
917 BLINDNESS 7 0.0002
918 HEART RATE INCREASED 17 0.0002
919 CONDITION AGGRAVATED 52 0.0002
920 DIZZINESS 82 0.0002
921 DISCOMFORT 10 0.0002
922 GYNAECOMASTIA 5 0.0002
923 VISION BLURRED 22 0.0002
924 ABDOMINAL PAIN LOWER 4 0.0002
925 FALL 52 0.0002
926 MYOCARDIAL INFARCTION 27 0.0002
927 NASAL CONGESTION 9 0.0002
928 NEPHROLITHIASIS 7 0.0002
929 INFLUENZA 17 0.0002
930 EYE DISORDER 5 0.0002
931 HYPERSENSITIVITY 28 0.0002
932 DISTURBANCE IN ATTENTION 8 0.0001
933 UNEVALUABLE EVENT 11 0.0001
934 BLISTER 8 0.0001
935 ANXIETY 40 0.0001
936 AGGRESSION 7 0.0001
937 ANGINA PECTORIS 4 0.0001
938 HYPOACUSIS 6 0.0001
939 WEIGHT INCREASED 31 0.0001
940 HOSPITALISATION 21 0.0001
941 THERAPY CESSATION 7 0.0001
942 BRONCHITIS 10 0.0001
943 OVERDOSE 29 0.0001
944 ARTHRALGIA 55 0.0001
945 URTICARIA 22 0.0001
946 CEREBROVASCULAR ACCIDENT 22 0.0001
947 TREATMENT NONCOMPLIANCE 7 0.0001
948 DRY MOUTH 10 0.0001
949 DYSPEPSIA 12 0.0001
950 LUNG NEOPLASM MALIGNANT 5 0.0001
951 INFLUENZA LIKE ILLNESS 10 0.0001
952 GAIT DISTURBANCE 23 0.0001
953 ABDOMINAL DISCOMFORT 20 0.0001
954 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
955 CONTUSION 11 0.0001
956 DRUG EFFECT INCOMPLETE 4 0.0001
957 PRURITUS 42 0.0001
958 COVID-19 19 0.0001
959 ASTHMA 12 0.0001
960 CATARACT 6 0.0001
961 FEELING HOT 6 0.0001
962 BLOOD GLUCOSE INCREASED 18 0.0001
963 DEPRESSED MOOD 5 0.0001
964 DIABETES MELLITUS 7 0.0001
965 ADVERSE DRUG REACTION 8 0.0001
966 DEPRESSION 20 0.0001
967 MEMORY IMPAIRMENT 12 0.0001
968 PROSTATE CANCER 7 0.0001
969 BURNING SENSATION 6 0.0001
970 DYSPHONIA 5 0.0001
971 PALPITATIONS 10 0.0001
972 INJURY 6 0.0001
973 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
974 MOBILITY DECREASED 6 0.0001
975 ADVERSE EVENT 7 0.0001
976 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
977 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
978 AMNESIA 4 0.0001
979 VISUAL IMPAIRMENT 7 0.0001
980 BREAST CANCER 5 0.0001
981 SWELLING 5 0.0001
982 MUSCLE SPASMS 9 0.0000
983 DRY SKIN 6 0.0000
984 RHEUMATOID ARTHRITIS 5 0.0000
985 PERIPHERAL SWELLING 6 0.0000
986 NASOPHARYNGITIS 7 0.0000
987 NO ADVERSE EVENT 6 0.0000
988 INCORRECT DOSE ADMINISTERED 7 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
990 FEELING ABNORMAL 6 0.0000